@ $20 and with current OS - CYDY will have market cap of $10 B For that to happen, they will need mono and cancer to be fully successful and launched.
EXEL with great product in renal cancer, generated $840 million in full year of launched and market cap of $7 B CYDY will have problems to reach these numbers with it’s structure